WNT5A and cardiovascular disorder: Previous studies unanimously reported that SFRP5 exerted an anti-inflammatory effect by inhibiting the non-canonical Wnt5a/JNK signaling pathway, therefore playing a key role in repressing the occurrence and development of various diseases including obesity, cardiovascular diseases, and diabetes [20].